Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "Mpower"

551 News Found

Amity awards Dr Azad Moopen Doctorate for Philanthropy
Sustainability | March 11, 2022

Amity awards Dr Azad Moopen Doctorate for Philanthropy

Over the last 35 years, Dr. Moopen – Founder Chairman and Managing Director of Aster DM Healthcare has played a phenomenal role in strengthening the healthcare delivery system in GCC


Aurobindo Pharma trains its managers to be `future ready’
News | March 11, 2022

Aurobindo Pharma trains its managers to be `future ready’

Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready


Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry
Biotech | March 09, 2022

Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry

Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder


Suvoda unveils new brand to reflect expanded focus in complex clinical trial management
Biotech | March 08, 2022

Suvoda unveils new brand to reflect expanded focus in complex clinical trial management

Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey


American Oncology Institute highlights spirit of women cancer survivors
Healthcare | March 08, 2022

American Oncology Institute highlights spirit of women cancer survivors

AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region


Sense receives CE marking for Veros Covid-19 instrument-free molecular test
Medical Device | March 08, 2022

Sense receives CE marking for Veros Covid-19 instrument-free molecular test

Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions


Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease
Drug Approval | March 07, 2022

Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease

OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)


Thermo Fisher Scientific unveils new genetic analyzer
Medical Device | March 07, 2022

Thermo Fisher Scientific unveils new genetic analyzer

Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers


WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site
Biotech | March 04, 2022

WuXi STA passes EMA drug product pre-approval inspection at its Wuxi City site

WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms


WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
News | March 04, 2022

WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements